Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
Marwan Sabbagh, MD, FAAN
Alireza Atri, MD, PhD
Christoph U. Correll, MD
Treatment of a Broader Population of Patients With DMD
Crystal Proud, MD
Erika Finanger, MD, MS
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
James R. Bateman, MD, MPH
Charles P. Vega, MD
B. Joy Snider, MD, PhD
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
Jerome A. Barakos, MD
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: Triage and Imaging in the Emergency Setting for Patients Prescribed Anti-Aβ mAbs
From Pathology to Practice: The Role of Inflammation in MS Pathology
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
Ahmed Z. Obeidat, MD, PhD
High-Efficacy DMTs: Transforming MS Care
Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
Long-Term Safety of DMTs: What We Know and What We Need to Know
Brain Health in MS: A Comprehensive Approach
Balancing Act: Immune Reconstitution vs Immune Suppression
Mastering ARIA Management: Charting the Path in a Virtual Clinic
Examining Emerging Gut Microbiota Biomarkers for MS
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.